INVO Fertility (IVF) Cash from Financing Activities (2011 - 2025)
INVO Fertility (IVF) reported Cash from Financing Activities of $1.6 million for Q3 2025, up 839.02% year-over-year from $169464.0 in Q3 2024, and up 10.37% sequentially from $1.4 million in Q2 2025.
INVO Fertility (IVF) Cash from Financing Activities (2011 - 2025) Analysis & Trends
INVO Fertility has disclosed Cash from Financing Activities across 14 years of filings, most recently posting $1.6 million for Q3 2025.
- Quarterly Cash from Financing Activities rose 839.02% year-over-year to $1.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $7.2 million (up 189.32% YoY) and the FY2024 annual result came in at $3.1 million, down 57.8% from the prior year.
- Cash from Financing Activities advanced to $1.6 million in Q3 2025, from $1.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $4.4 million in Q3 2023 and bottomed at -$169856.0 in Q2 2023.
- The 5-year median for Cash from Financing Activities is $663683.0 (2022), against an average of $1.4 million.
- The widest YoY moves for Cash from Financing Activities: up 17753.12% in 2023, down 117.69% in 2023.
- INVO Fertility's Cash from Financing Activities stood at $3.4 million in 2021, then tumbled by 76.48% to $800000.0 in 2022, then sank by 117.69% to -$141527.0 in 2023, then surged by 449.09% to $494050.0 in 2024, then surged by 222.09% to $1.6 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.6 million, $1.4 million, and $3.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 494,050.00 |
| Dec 31, 2024 | 494,050.00 |
| Sep 30, 2024 | 169,464.00 |
| Sep 30, 2024 | 169,464.00 |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 527,366.00 |
| Mar 31, 2024 | 527,366.00 |
| Dec 31, 2023 | -141,527.00 |
| Dec 31, 2023 | -141,527.00 |
| Sep 30, 2023 | 4.45 Mn |
| Sep 30, 2023 | 4.45 Mn |
| Jun 30, 2023 | -169,856.00 |
| Jun 30, 2023 | -169,856.00 |